ID   BW-1100.129.237
AC   CVCL_RW62
SY   BWalpha-beta-; alpha(-)beta(-) BW5147; TCRalpha-beta- BW5147
DR   Wikidata; Q54798694
RX   PubMed=2778316;
RX   PubMed=32419056;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Does not express functional TCR alpha and beta chains.
CC   Doubling time: ~18 hours (PubMed=2778316).
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW61 ! BW-1100.129
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=2778316; DOI=10.4049/jimmunol.143.6.1822;
RA   White J., Blackman M., Bill J., Kappler J.W., Marrack P., Gold D.P.,
RA   Born W.K.;
RT   "Two better cell lines for making hybridomas expressing specific T
RT   cell receptors.";
RL   J. Immunol. 143:1822-1825(1989).
//
RX   PubMed=32419056; DOI=10.1007/s00005-020-00579-1;
RA   White J., O'Brien R.L., Born W.K.;
RT   "BW5147 and derivatives for the study of T cells and their antigen
RT   receptors.";
RL   Arch. Immunol. Ther. Exp. 68:15-15(2020).
//